Scarica l'app Stockscreener
3.2101
1.97%
-0.0849
Elicio Therapeutics Inc Borsa (ELTX) Ultime notizie
Elicio Therapeutics closes $15 million stock offering - Investing.com
Elicio Therapeutics Closes $15 Million Registered Direct Offering - marketscreener.com
Elicio closes $15M stock sale to fund KRAS cancer trial work - Stock Titan
Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirt - The National Law Review
Price to sales forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Elicio Therapeutics stock tumbles on $15M offering - Investing.com
Elicio Therapeutics stock tumbles on $15M offering By Investing.com - Investing.com Australia
Form 424B5 Elicio Therapeutics Inc For: 2 July By Investing.com - Investing.com India
Elicio Therapeutics (ELTX) raises ~$15.0M via 4.38M-share placement - Stock Titan
Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment - TradingView
Elicio Therapeutics raises $15M in registered direct offering By Investing.com - Investing.com Australia
Elicio Therapeutics Prices $15 Million Registered Direct Offering at $3.43; Signs Purchase, Placement Pacts - TradingView
Elicio Therapeutics (ELTX) prices $15M registered direct equity offering - Stock Titan
Elicio Therapeutics Prices $15 Million Direct Offering - marketscreener.com
Elicio locks in $15M to fund Phase 1 KRAS cancer trial - Stock Titan
Elicio Therapeutics prices $15M stock offering to fund cancer immunotherapy trials. - Pluang
Elicio Therapeutics raises $15M in registered direct offering - Investing.com
Elicio Therapeutics Also Plans to Use Net Proceeds for Working Capital, General Corporate Purpose >ELTX - Moomoo
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - GlobeNewswire
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - GlobeNewswire Inc.
Price to book forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc.ELTX - FinancialContent
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therapeutics, Inc. (ELTX) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therap - The National Law Review
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2000 Index - marketscreener.com
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2500 Growth Benchmark - marketscreener.com
Elicio Therapeutics, Inc.(NasdaqCM:ELTX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Elicio Therapeutics Joins Russell 2000 and 3000 Indexes (ELTX) - GuruFocus
Elicio Therapeutics added to Russell 2000 and 3000 indexes - Investing.com
Elicio Therapeutics added to Russell 2000 and 3000 indexes By Investing.com - Investing.com South Africa
Elicio Therapeutics, Inc.(NasdaqCM:ELTX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes - The Manila Times
Elicio Therapeutics joins Russell indexes after annual reconstitution - Stock Titan
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2000 Growth Benchmark - marketscreener.com
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 3000E Growth Benchmark - marketscreener.com
Elicio Therapeutics, Inc.(NasdaqCM:ELTX) added to Russell Small Cap Completeness Index - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
2026-06-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Stockholders to Learn More About the Investigation | NDAQ:ELTX | Press Release - Stockhouse
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) dropped from Russell 3000E Value Benchmark - marketscreener.com
Elicio Therapeutics, Inc Actuals & Estimates (NASDAQ:ELTX) - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Elicio Therapeutics, Inc. (ELTX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Elicio Therapeutics - The National Law Review
ELTX Forecast — Price Target — Prediction for 2027 - TradingView
Elicio Therapeutics, Inc Actuals & Estimates (LSX:A3CY4J) - TradingView
ELTX Investors Have Opportunity to Join Elicio Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - The National Law Review
A3CY4J Forecast — Price Target — Prediction for 2027 - TradingView
Elicio Therapeutics (ELTX) outlines ELI-002 7P combo trial plan in metastatic pancreatic cancer - Stock Titan
ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints - Stocktwits
Elicio Therapeutics (ELTX) Drops 4.14% as Bearish Momentum Tests Key SupportFactor Rotation - dars.gov.et
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio ... - Caledonian Record
Elicio Therapeutics Inc (ELTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
H.C. Wainwright reiterates Elicio Therapeutics stock rating at buy By Investing.com - Investing.com Canada
H.C. Wainwright Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Elicio Therapeutics Inc (ELTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elicio Therapeutics (ELTX) Corporate presentation Summary - Quartr
Elicio Therapeutics (ELTX) Registration Filing Summary - Quartr
Elicio Therapeutics Inc. (NASDAQ: ELTX) Stock Price, News & Analysis - Kalkine
Ladenburg Thalmann starts Elicio Therapeutics stock at buy By Investing.com - Investing.com Australia
1.53%
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):